首页    期刊浏览 2024年12月04日 星期三
登录注册

文章基本信息

  • 标题:Lipid Biomarkers in Depression: Does Antidepressant Therapy Have an Impact?
  • 本地全文:下载
  • 作者:Fidelis Christin Stuchtey ; Andrea Block ; Francis Osei
  • 期刊名称:Healthcare
  • 电子版ISSN:2227-9032
  • 出版年度:2022
  • 卷号:10
  • 期号:2
  • DOI:10.3390/healthcare10020333
  • 语种:English
  • 出版社:MDPI Publishing
  • 摘要:Studies have revealed mixed results on how antidepressant drugs affect lipid profiles of patients with major depression disorder (MDD). Even less is known about how patients respond to a switch of antidepressant medication with respect to their metabolic profile. For this, effects of a switch in antidepressants medication on lipid markers were studied in MDD patients. 15 participants (females = 86.67%; males = 13.33%; age: 49.45 ± 7.45 years) with MDD and a prescribed switch in their antidepressant medication were recruited at a psychosomatic rehabilitation clinic. Participants were characterized (with questionnaires and blood samples) at admission to the rehabilitation clinic (baseline, T0) and followed up with a blood sample two weeks (T1) later. HDL, LDL, total cholesterol, and triglycerides were determined (T0), and their change analyzed (Wilcoxon test) at follow up (T1). Decrements in HDL ( p = 0.041), LDL ( p < 0.001), and total cholesterol ( p < 0.001) were observed two weeks after a switch in antidepressant medication. Triglycerides showed no difference ( p = 0.699). Overall, LDL, HDL, and total cholesterol are affected by a change in antidepressant drugs in patients with MDD. These observations are of clinical relevance for medical practitioners in the planning and management of treatment strategies for MDD patients.
  • 关键词:enmajor depressive disorderantidepressantshigh density lipoprotein cholesterolHDLlow density lipoprotein cholesterolLDLcholesteroltriglycerideslipids
国家哲学社会科学文献中心版权所有